"An excellent attorney who steers clients through troubled merger review proceedings."
Chambers USA 2024
"Always has great insight."
Chambers USA 2024
"A pleasure to work with. He is very responsive to client needs for updates and information."
Chambers USA 2024
"Has a proven track record in representing clients within the technology and life sciences sectors."
The Legal 500 US 2024
Leading Lawyer ‒ Antitrust: Merger Control
The Legal 500 US 2024
"His expertise and depth in cross-border matters is legendary."
Chambers USA 2021
"He's very strategic and thoughtful and with his experience working in Europe he brings a lot of that to the table."
Chambers USA 2023
"An excellent attorney who steers clients through troubled merger review proceedings."
Chambers USA 2022
Global Elite Thought Leader – Competition
Who's Who Legal 2024
"Michael is very pragmatic, business-orientated, and thinks of outside-the-box ideas."
Chambers USA 2022
"Michael Egge has an accomplished merger clearance practice and often acts for multinational corporations."
Chambers USA 2021
Profile
Michael Egge secures regulatory clearances for transformative global transactions and defends clients in high stakes cross-border investigations.
Leveraging more than 30 years of experience and a broad international perspective, Michael advises market leaders on a full spectrum of their most complex antitrust challenges, including investigations of:
Strategic transactions
Alleged cartel conduct
Conduct investigations brought by US and European enforcers
Michael is widely regarded for his experience in clearing major transactions that require navigating merger control requirements around the world. He has appeared and argued before antitrust authorities in countries across North America, South America, Europe, and Asia.
A recognized leader at the firm, Michael is Chair of the firm’s Global Antitrust & Competition Practice and has played a pivotal role in building one of the most comprehensive global antitrust practice platforms in the world today. From 2006 to 2015, he led Latham’s Global Antitrust & Competition Practice Group, including three years (2012-2015) resident in the Brussels office, where he helped expand Latham & Watkins’ practice before the European Commission.Michael was Managing Partner of the Washington, D.C. office from 2016 to 2020, and he served on the firm’s Executive Committee from 2020 to 2024.
Michael speaks frequently on antitrust issues and has served in a variety of leadership positions within the American Bar Association’s Antitrust Law Section, including as a member of its governing Council, Co-Chair of the Annual Spring Meeting, Chair of the Merger Process Working Group, and Chair of several of its expert conferences.
He maintains an active pro bono practice, including on behalf of the Osteosarcoma Collaborative, a nonprofit organization for which he is a founding member that brings together data, researchers, patients, and families to find new cures for the disease.
Experience
Michael's experience includes representing:
Bunge Limited, a US grains merchant manufacturer, in obtaining global merger control and FDI clearances in more than 30 jurisdictions for its planned US$34 billion merger with Viterra
EssilorLuxottica in:
Its US$6 billion acquisition of GrandVision
Acquiring US-based lab network Walman
GRAIL in its US$8 billion acquisition by Illumina and novel post-closing litigation at the FTC
Siemens Healthineers in its US$16.4 billion acquisition of VarianMedical Systems
Agrium in its US$36 billion merger of equals with PotashCorp of Saskatchewan to create Nutrien
Nestle Health Sciences in its acquisitions of Vital Proteins, Nature’s Bounty, and Orgain
Dairy Farmers of America in its US$433 million acquisition of Dean Foods
Time Warner Cable in its US$55 billion merger with Charter
American Airlines in its successful bid for antitrust immunity for its joint business alliance with Qantas Airways
FMC Technologies in its US$13 billion merger with Technip SA
Siemens in its US$7.6 billion acquisition of Dresser-Rand
Leading players in the auto parts and chemical industries in securing amnesty protection
Qualifications
Bar Qualification
District of Columbia
Education
JD, University of Virginia School of Law, 1991 Notes Editor, Virginia Law Review
AB in Economics, College of William & Mary, 1988 with high honors
In the leading competition publication’s annual review of the strongest antitrust practices around the globe, the firm dominated in every category, ranking second across all specialties.
Multidisciplinary team represents the NASDAQ-listed technology solutions provider at the intersection of robotics, sensors, software analytics, and connectivity in all-stock transaction.
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.